MML Investors Services
BLUE

MML Investors Services’s bluebird bio BLUE Stock Holding History

MML Investors Services’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-185
Closed -$211K – 1404
2019
Q4 		$211K Buy
185
+16
+9% +$17.4K ﹤0.01% 1407
2019
Q3 		$201K Sell
169
-125
-43% -$191K ﹤0.01% 1398
2019
Q2 		$485K Buy
294
+11
+4% +$19K 0.01% 1038
2019
Q1 		$577K Buy
283
+49
+21% +$86.3K 0.01% 940
2018
Q4 		$300K Buy
234
+98
+72% +$150K 0.01% 1172
2018
Q3 		$258K Buy
+136
New +$281K ﹤0.01% 1348

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MML Investors Services's BLUE Position: Q1 2020 in Review

MML Investors Services sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 185 shares — an estimated $211K sold.

MML Investors Services first reported a position in BLUE in Q3 2018 and held it in 6 quarters. The position peaked at $577K in Q1 2019. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

  • MML Investors Services reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
  • MML Investors Services sold 185 bluebird bio shares in Q1 2020, an estimated $211K.
  • MML Investors Services first reported a position in bluebird bio in Q3 2018 and held it in 6 quarters.
  • MML Investors Services's bluebird bio position peaked at $577K in Q1 2019.
  • 247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on MML Investors Services's 13F filing for Q1 2020, filed 14 May 2020.